Effects of loratadine and terfenadine on the induced nasal allergic reaction

Archives of Otolaryngology - Head and Neck Surgery

Volumn 122, Issue 3, 1996, Pages 309-316

  Baroody, Fuad M ^a,b,c   Lim, Margaret C ^a   Proud, David ^a   Kagey Sobotka, Anne ^a   Lichtenstein, Lawrence M ^a   Naclerio, Robert M ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALLERGEN; ANTIHISTAMINIC AGENT; HISTAMINE; KININ; LEUKOTRIENE C4; LORATADINE; METHACHOLINE CHLORIDE; PLACEBO; PROSTAGLANDIN D2; TERFENADINE; TRYPTASE;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; EOSINOPHIL; FEMALE; HUMAN; MALE; NOSE ALLERGY; NOSE SECRETION; ORAL DRUG ADMINISTRATION; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SNEEZING;

EID: 0029960837     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.1996.01890150083015     Document Type: Article

References (26)

1. Druce HM, Wright RH, Kossoff D, Kaliner MA Cholinergic nasal hyperresponsiveness in atopic subjects. J Allergy Clin Immunol. 1985,76:445-452
2. White MV Nasal cholinergic hyperresponsiveness in atopic subjects studied out of season J Allergy Clin Immunol. 1993;92:278-287
3. Borum P Nasal methacholine challenge a test for the measurement of nasal reactivity J Allergy Clin Immunol. 1979;63:253-257
4. Walden SM, Proud D, Lichtenstein LM, Kagey-Sobotka A, Naclerio RM. Antigen-provoked increase in histamine reactivity: observations on mechanisms. Am Rev Respir Dis. 1991;143:642-648.
5. Klementsson H, Andersson M, Baumgarten CR, Venge P, Pipkorn U. Changes in non-specific nasal reactivity and eosinophil influx and activation after allergen challenge. Clin Exp Allergy. 1990,20:539-547.
6. Baroody FM, Cruz M, Lichtenstein LM, Kagey-Sobotka A, Proud D, Naclerio RM Intranasal beclomethasone inhibits antigen-induced nasal hyperresponsiveness to histamine J Allergy Clin Immunol 1992;90:373-376.
7. Andersson M, Andersson P, Pipkorn U. Allergen-induced specific and nonspecific nasal reactions reciprocal relationship and inhibition by topical glucocorticosteroids. Acta Otolaryngol (Stockh). 1989;107 270-277
8. Klementsson H, Andersson M, Pipkorn U Allergen-induced increase in nonspecific nasal reactivity is blocked by antihistammes without a clear-cut relationship to eosinophil influx. J Allergy Clin Immunol 1990;86:466-472
9. Klementsson H, Svensson C, Andersson M, Venge P, Pipkorn U, Persson CGA Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the nasal mucosa during a weak pollen season Clin Exp Allergy. 1991;21:705-710.
10. Baroody FM, Wagenmann M, Naclerio RM A comparison of the secretory response of the nasal mucosa to histamine and methacholine. J Appl Physiol. 1993,74.2661-2671
11. Naclerio RM, Meier HL, Kagey-Sobotka A, et al. Mediator release after airway challenge with antigen. Am Rev Respir Dis. 1983;128 597-602
12. Majchel AM, Baroody F, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Effect of oxymetazoline on the early response to nasal challenge with antigen J Allergy Clin Immunol. 1993;92:767-770.
13. Siragaman R. An automated continuous flow system for the extraction and fluorometric analysis of histamine. Anal Biochem. 1974;57.283-294.
14. Imanari T, Kaizu T, Yoshida H, Yates K, Pierce JV, Pisano JJ. Radiochemical assays for human urinary, salivary and plasma kallikreins. In: Pisano JJ, Austen KF, eds. Chemistry and Biology of the Kallikrein-Kinin System in Health and Disease. Washington, DC. Government Printing Office; 1976:205-213. US Department of Health, Education, and Welfare publication (NIH) 76-791
15. Baumgarten CR, Togias AG, Naclerio RM, Lichtenstein LM, Norman PS, Proud D. Influx of kininogens into nasal secretions following antigen challenge of allergic individuals J Clin Invest. 1985;76:191-197.
16. Proud D, Bailey GS, Naclerio RM, et al. Tryptase and histamine as markers to evaluate mast cell activation during the responses to nasal challenge with allergen, cold, dry air, and hyperosmolar solutions. J Allergy Clin Immunol. 1992; 89:1098-1110
17. Togias AG, Proud D, Kagey-Sobotka A, Norman P, Lichtenstein L, Naclerio R. The effect of a topical tricyclic antihistamme on the response of the nasal mucosa to challenge with cold, dry air and histamine. J Allergy Clin Immunol. 1987;79.599-604
18. Roth T, Roehrs T, Koshorek G, Sicklesteel J, Zorick F. Sedative effects of antihistamines. J Allergy Clin Immunol. 1987;80:94-98.
19. Sorkin EM, Heel RC. Terfenadine, a review of its pharmacodynamic properties and therapeutic efficacy. Drugs. 1985;29:34-56.
20. Clissold SP, Sorkin EM, Goa KL Loratadine: a preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1989;37:42-57.
21. 1-receptor antagonists assessed by nasal challenge. J Allergy Clin Immunol. 1988, 82:881-887.
22. 1 antihistamine, inhibits histamine release in vivo in the human. Am Rev Respir Dis. 1990,142:167-171.
23. Wagenmann M, Baroody FM, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. The effect of terfenadine on unilateral nasal challenge with allergen J Allergy Clin Immunol. 1994;93:594-605.
24. Schwartz LB. Monoclonal antibodies against human mast cell tryptase demonstrate shared antigenic sites on subunits of tryptase and selective localization of the enzyme to mast cells J Immunol. 1985,134:526-531.
25. Barnett A, Iorio LC, Kreutner W, Tozzi S, Ahn HS, Gulbenkian A. Evaluation of the CNS properties of SCH 29851, a potential nonsedating antihistamine Agents Actions Suppl 1984;14:590-597.
26. Majchel AM, Proud D, Freidhoff L, Creticos PS, Norman PS, Naclerio RM. The nasal response to histamine challenge effect of the pollen season and immunotherapy. J Allergy Clin Immunol. 1992;90 85-91.